Researcher Profiles

Man Ying Li

Adelaide Medical School

Faculty of Health and Medical Sciences

Career
Publications
Contact

Awards and Achievements

Date	Type	Title	Institution Name	Country	Amount
2022	Award	Basil Hetzel Institute Travel Grant Awards	BHI, TQEH	Australia	-
2021	Award	Best Oral Presentation Prize for Junior Laboratory Research	TQEH	Australia	-
2020	Scholarship	Faculty of Health and Medical Science Divisional Scholarships	The Univeristy of Adelaide	Australia	-
2019	Achievement	First Class Honours in Bachelor of Health and Medical Sciences	The University of Adelaide	Australia	-
2019	Award	THRF Honours Scholarships	The Hospital Research Foundation	Australia	-
2019	Scholarship	Summer Research Scholarships	The University of Adelaide and SAHMRI	Australia	-

Education

Date	Institution name	Country	Title
2020 - 2024	University of Adelaide	Australia	PhD
2019 - 2019	University of Adelaide	Australia	Honours degree
2016 - 2018	University of Adelaide	Australia	Bachelor of Biomedical Science

Journals

Year	Citation
2024	Man Ying Li, C., Li, R., Drew, P., Price, T., Smith, E., Maddern, G. J., . . . Fenix, K. (2024). Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: current strategies and future challenges. Cancer Treatment Reviews, 122, 102665-1-102665-11. DOI Scopus9 Europe PMC4
2024	Li, C. M. Y., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2024). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. Cancer Immunology Immunotherapy, 73(1), 6-1-6-16. DOI Scopus1 Europe PMC1
2024	Li, C. M. Y., Briggs, M. T., Lee, Y. -R., Tin, T., Young, C., Pierides, J., . . . Fenix, K. (2024). Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.. Clin Exp Med, 24(1), 53. DOI Scopus3 Europe PMC2
2024	Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Diagnostic and prognostic significance of circulating secreted frizzled-related protein 5 in colorectal cancer. Cancer Medicine, 13(11), e7352-1-e7352-11. DOI Europe PMC1
2023	Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages. DOI Scopus3 WoS1 Europe PMC3
2023	Li, C. M. Y., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. A. (2023). Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer, 11(4), e006764-1-e006764-17. DOI Scopus14 WoS4 Europe PMC11
2022	Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages. DOI Scopus12 WoS7 Europe PMC12

Email: manying.li@adelaide.edu.au

Connect With Me

External Profiles